Literature DB >> 19139378

Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2.

Denis J Glenn1, Feng Wang, Songcang Chen, Minobu Nishimoto, David G Gardner.   

Abstract

Increased B-type natriuretic peptide (BNP) gene expression is regarded as one of the hallmarks of cardiac myocyte hypertrophy. Here we demonstrate that both basal- and endothelin-1-dependent stimulation of human (h) BNP gene transcription requires the presence of an intact Yin Yang 1 (YY1) binding site positioned at -62 bp relative to the transcription start site. Mutation of this site reduced both basal and stimulated hBNP promoter activity. This site was shown to bind YY1 both in vitro and within the context of the intact cell. The latter interaction increased after endothelin-1 treatment. Exposure to endothelin-1 also resulted in increased nuclear localization of YY1 and a reduction in acetylation of the YY1 protein. Overexpression of wild-type YY1 increased both basal and endothelin-stimulated hBNP promoter activity, whereas a carboxy-terminal deletion mutant of YY1 was devoid of activity. Treatment with the histone deacetylase inhibitor trichostatin A resulted in decreased hBNP reporter activity. YY1 was shown to associate with histone deacetylase 2, and histone deacetylase 2 was shown to associate directly with the hBNP promoter in the intact cell. Collectively these findings demonstrate that YY1 plays an important role in regulating the transcriptional activity of the hBNP gene promoter. These data suggest a model in which YY1 activates hBNP transcription through interaction with histone deacetylase 2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139378      PMCID: PMC2710878          DOI: 10.1161/HYPERTENSIONAHA.108.125088

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

1.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.

Authors:  R W Troughton; C M Frampton; T G Yandle; E A Espiner; M G Nicholls; A M Richards
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

2.  Functional interaction of NF-Y and Sp1 is required for type a natriuretic peptide receptor gene transcription.

Authors:  F Liang; F Schaufele; D G Gardner
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases.

Authors:  J Lu; T A McKinsey; C L Zhang; E N Olson
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

4.  Cooperative activation by GATA-4 and YY1 of the cardiac B-type natriuretic peptide promoter.

Authors:  S S Bhalla; L Robitaille; M Nemer
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

5.  Lentiviral strategies for RNAi knockdown of neuronal genes.

Authors:  Jill R Crittenden; Amy Heidersbach; Michael T McManus
Journal:  Curr Protoc Neurosci       Date:  2007-04

6.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

7.  Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.

Authors:  L Katherine Morrison; Alex Harrison; Padma Krishnaswamy; Radmila Kazanegra; Paul Clopton; Alan Maisel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

8.  Regulation of transcription factor YY1 by acetylation and deacetylation.

Authors:  Y L Yao; W M Yang; E Seto
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

9.  Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy.

Authors:  Peter D Mariner; Stephen W Luckey; Carlin S Long; Carmen C Sucharov; Leslie A Leinwand
Journal:  Biochem Biophys Res Commun       Date:  2005-01-07       Impact factor: 3.575

Review 10.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Authors:  Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2007-07-21       Impact factor: 5.000

View more
  22 in total

1.  Transgenic over-expression of YY1 induces pathologic cardiac hypertrophy in a sex-specific manner.

Authors:  Brian L Stauffer; Karen Dockstader; Gloria Russell; Jamie Hijmans; Lisa Walker; Mackenzie Cecil; Kimberly Demos-Davies; Allen Medway; Timothy A McKinsey; Carmen C Sucharov
Journal:  Biochem Biophys Res Commun       Date:  2015-04-29       Impact factor: 3.575

Review 2.  Epigenetic Mechanisms and Hypertension.

Authors:  Mingyu Liang
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

3.  miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.

Authors:  Youngmi Kim; Deokbum Park; Hyuna Kim; Munseon Choi; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

Review 4.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 5.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

Review 6.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

Review 7.  Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Authors:  Hae Jin Kee; Hyun Kook
Journal:  J Biomed Biotechnol       Date:  2010-11-29

8.  Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes.

Authors:  Huaping Shi; Lei Chen; Huilan Wang; Shoukang Zhu; Chunming Dong; Keith A Webster; Jianqin Wei
Journal:  Biochem Biophys Res Commun       Date:  2012-11-29       Impact factor: 3.575

Review 9.  Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.

Authors:  Eunah Kim; William H Bisson; Christiane V Löhr; David E Williams; Emily Ho; Roderick H Dashwood; Praveen Rajendran
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

10.  Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.

Authors:  Bradley S Ferguson; Brooke C Harrison; Mark Y Jeong; Brian G Reid; Michael F Wempe; Florence F Wagner; Edward B Holson; Timothy A McKinsey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.